MEETINGS - Australia's health 2006 (Australia) June 2006:
This article was originally published in Clinica
The Australian Institute of Health and Welfare (AIHW) will host the conference Australia's health 2006 on June 21 at the Hyatt Hotel Canberra, Yarralumla. Discussions will focus on health services and resources, trends and concerns in public health and chronic diseases. For further information and to register, contact Kirsty Leversha on tel: +61 2 6244 1032; fax: +61 2 6244 1045.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.